Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
4(36%)
Results Posted
17%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_3
5
45%
Ph phase_1
6
55%

Phase Distribution

6

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
6(54.5%)
Phase 3Large-scale testing
5(45.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

4

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(6)
Terminated(1)

Detailed Status

Completed6
Recruiting2
Active, not recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
4
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (54.5%)
Phase 35 (45.5%)

Trials by Status

recruiting218%
completed655%
terminated19%
active_not_recruiting218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11